Navigation Links
Savient Pharmaceuticals Receives Complete Response Letter from U.S. Food and Drug Administration for KRYSTEXXA(TM)
Date:8/2/2009

all and will be available for 14 days. To access the recording, use the dial-in number and the Conference ID listed below.

Dial: 888-203-1112 (domestic) or 719-457-0820 (international)

Conf ID: 9640146

ABOUT SAVIENT PHARMACEUTICALS, INC.

Savient Pharmaceuticals, Inc. is a specialty biopharmaceutical company focused on developing and marketing pharmaceutical products that target unmet medical needs in both niche and broader specialty markets. Savient has developed one product: KRYSTEXXA(TM) (pegloticase) which is a PEGylated uricase enzyme intended for the treatment of chronic gout in patients refractory to conventional therapy. Savient has exclusively licensed worldwide rights to the technology related to KRYSTEXXA, formerly referred to as Puricase(R), from Duke University and Mountain View Pharmaceuticals, Inc. Savient also manufactures and supplies Oxandrin(R) (oxandrolone tablets, USP) CIII in the U.S. Further information on Savient can be accessed by visiting: http://www.savient.com. Puricase is a registered trademark of Mountain View Pharmaceuticals, Inc.

FORWARD-LOOKING LANGUAGE

All statements other than statements of historical facts included in this press release are forward-looking statements that are subject to certain risks, trends and uncertainties that could cause actual results and achievements to differ materially from those expressed in such statements. These risks, trends and uncertainties are in some instances beyond our control. Words such as "anticipate," "believe," "estimate," "expect," "intend," "plan," "will" and other similar expressions identify forward-looking statements, although not all forward-looking statements contain these identifying words. In particular, any statements regarding potential FDA marketing approval for KRYSTEXXA(TM
'/>"/>

SOURCE Savient Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Savient Pharmaceuticals to Present at the Credit Suisse Phoenix Healthcare Conference on November 13th
2. Savients Board of Directors Forms a Board Committee to Oversee the Regulatory and Pre-Launch Activities for Pegloticase
3. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
4. Savient Pharmaceuticals Reports Fourth Quarter and Year-End 2008 Financial Results
5. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
6. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
7. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
10. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
11. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Quincy Bioscience, makers of the nation’s leading memory ... release of the fourth edition of The Brain Health ... , The Brain Health Guide is a unique resource ... to improve memory and promote optimal aging. Rather than ... Guide provides ways to help minimize common memory lapses ...
(Date:7/28/2014)... to treat severe chronic migraine headaches led to significant ... in patients treated at Massachusetts General Hospital (MGH). ... Surgery report that more than half of 35 patients ... had headaches associated with compression of craniofacial nerves ... team,s paper has received advance online publication in the ...
(Date:7/28/2014)... Massachusetts (PRWEB) July 28, 2014 ... Summit Provider Exchange technology solution in ... integration efforts and support collaboration with their New ... bed acute-care medical center located in New Jersey, ... seasonal visitors with a variety of inpatient and ...
(Date:7/28/2014)... News) -- Endurance runners are far more likely to ... according to a new study. The researchers ... warm climates are actually 10 times more likely to ... common sudden death of a young and apparently healthy ... irregular heartbeat, often gets a lot more media attention. ...
(Date:7/28/2014)... Michigan (PRWEB) July 28, 2014 The ... Drs. Harris, Birkhill, Wang, Songe and Associates, PC that ... and countless tomorrows to come. , The HBWS ... responsible for more than $2.5 million in donations. Through ... title sponsors for the Oakwood Women’s Healthcare Classic for ...
Breaking Medicine News(10 mins):Health News:Quincy Bioscience Launches the Fourth Edition of The Brain Health Guide 2Health News:Non-endoscopic migraine surgery provides significant symptom relief 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 2Health News:Cape Regional Medical Center Chooses Summit Provider Exchange to Connect With NJSHINE and Physician Offices 3Health News:Heat Stroke a Greater Threat to Endurance Runners Than Heart Problems: Study 2
... related to stomach like diarrhoea, food poisoning and indigestion ... this festive season. NHS Direct is// a telephone and ... 0845 46 47. ,Stomach ache, tooth ache ... during the festive period. ,NHS Direct got ...
... all the talk about going the extra mile to make ... a survey has revealed the disappointing// negativism prevailing in the ... ,Nearly 27% of Britons who responded to the survey by ... denied the strength of personal efforts in preventing the disease. ...
... uric acid might have a say in whether an elderly ... , ,The study published in the January issue of Neuropsychology, ... at 96 community-dwelling adults aged 60 to 92 years old. ... high-normal range, defined as 5.8 to 7.6 milligrams per deciliter ...
... teenage girls might want to have another look at ... ,According to recent studies, teenage girls who read articles ... more prone to resort to drastic weight reducing techniques ... those who don’t. ,The study, published in Pediatrics' ...
... been developed that can help predict the risk ... pleocytosis (presence of greater// number of white blood ... according to a study. ,Although ... and treating children with cerebrospinal fluid (CSF) pleocytosis, ...
... Ramadev is a busy man today; fielding complaints from the ... of being taken to court, from an NGO.// ... claimed to hold the key to curing AIDS by performing ... Ramadoss had earlier rubbished these statements, saying while he supported ...
Cached Medicine News:Health News:Drop That Glossy, Girl! 2Health News:Clinical Guidelines Help Identify Which Children at Risk of Bacterial Meningitis 2
(Date:7/28/2014)...  Syneron Medical Ltd. (NASDAQ: ELOS ), ... its new PicoWay® device has received CE Mark indication ... pigmented lesions on any skin type. PicoWay is a ... 1064nm wavelengths, which utilizes Syneron,s proprietary PicoWay technology to ... trillionths of a second, known as picosecond pulses. Syneron ...
(Date:7/28/2014)... -- ResMed (NYSE: RMD ), innovatore e ... disturbi respiratori del sonno (SDB) e altre patologie croniche ... contro il produttore Taiwanese di dispositivi medicali, APEX Medical ... indossare in testa, che violano i brevetti, utilizzate con ... della Corte Regionale Distrettuale di Monaco ...
(Date:7/28/2014)... TOKYO , July 28, 2014  ImaginAb, Inc. ... Roger Crystal , MD as Vice President of Business ... Business Development Product Acquisition & Licensing team at G.E. ... business strategy and partnerships in the precision medicine space ... with biotechnology and pharmaceutical companies across the spectrum to ...
Breaking Medicine Technology:Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 2Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 3Syneron Announces CE Mark for PicoWay Dual Wavelength Picosecond Laser for Tattoo Removal and Treatment of Pigmented Lesions 4ResMed riceve un'ingiunzione permanente contro APEX in Germania, continua a far valere i propri diritti per i brevetti in Europa 2ImaginAb Appoints Roger Crystal, MD as Vice President of Business Development 2
... online marketplace for medical equipment , is pleased to ... Medical Equipment Parts Finder service. As it is often ... for medical equipment and devices, MedWOW,s R&D staff developed this ... the parts they need through MedWOW,s standard parts and accessories ...
... China, Nov. 1, 2010 /PRNewswire-Asia-FirstCall/ -- China Nepstar Chain ... or the "Company"), the largest drugstore chain in China ... today that the company will report its third quarter ... the market opens. The Company will host ...
Cached Medicine Technology:MedWOW Adds Parts Finder Service and Enhances Business Model 2China Nepstar Chain Drugstore to Report Third Quarter 2010 Financial Results on November 17, 2010 2
... 2.2 offers extremely high resolution treatment capability ... an exceptionally wide 78° field of view. ... critical evaluation of the optic nerve head ... of the macula and disc. Redesigned to ...
... is excellent for critically evaluating and ... macular degeneration, retinal vascular occlusions, diabetic ... other retinal conditions. It is ideal ... conditions providing excellent magnification combined with ...
... 130° QuadrAspheric lens has grown in popularity ... preferred wide field fundus laser lens. Its ... advantage over competitive wide field lenses for ... of use. This lens is excellent for ...
... Wide Field Lens combines exceptional ... magnification. The enhanced double aspheric ... high resolution stereo views of ... These unique features make it ...
Medicine Products: